13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001964437-24-000007
Total Value
$264.6M
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARGENX SE | ARGX | 64,196 | $27.6M | 10.43% |
| 2 | DISC MEDICINE INC | IRON | 503,089 | $22.7M | 8.57% |
| 3 | CRINETICS PHARMACEUTICALS IN | CRNX | 479,681 | $21.5M | 8.12% |
| 4 | VAXCYTE INC | PCVX | 215,680 | $16.3M | 6.15% |
| 5 | ASCENDIS PHARMA A/S | ASND | 113,224 | $15.4M | 5.83% |
| 6 | CYTOKINETICS INC | CYTK | 272,036 | $14.7M | 5.57% |
| 7 | BIOMARIN PHARMACEUTICAL INC | BMRN | 178,589 | $14.7M | 5.56% |
| 8 | COGENT BIOSCIENCES INC | COGT | 1,673,919 | $14.1M | 5.33% |
| 9 | CARGO THERAPEUTICS INC | 14179K101 | 856,849 | $14.1M | 5.32% |
| 10 | KALVISTA PHARMACEUTICALS INC | KALV | 1,128,478 | $13.3M | 5.02% |
| 11 | CELCUITY INC | CELC | 760,941 | $12.5M | 4.71% |
| 12 | MERUS N V | N5749R100 | 164,773 | $9.7M | 3.68% |
| 13 | SYNDAX PHARMACEUTICALS INC | SNDX | 419,654 | $8.6M | 3.26% |
| 14 | ABIVAX SA | AAVXF | 627,760 | $8.3M | 3.14% |
| 15 | IRONWOOD PHARMACEUTICALS INC | IRWD | 1,113,824 | $7.3M | 2.74% |
| 16 | AMICUS THERAPEUTICS INC | FOLD | 713,536 | $7.1M | 2.67% |
| 17 | ANAPTYSBIO INC | ANABV | 249,609 | $6.3M | 2.36% |
| 18 | PHATHOM PHARMACEUTICALS INC | PHAT | 593,306 | $6.1M | 2.31% |
| 19 | ITEOS THERAPEUTICS INC | 46565G104 | 367,429 | $5.5M | 2.06% |
| 20 | INOZYME PHARMA INC | 45790W108 | 1,140,310 | $5.1M | 1.92% |
| 21 | NEUMORA THERAPEUTICS INC. | NMRA | 390,084 | $3.8M | 1.45% |
| 22 | ENLIVEN THERAPEUTICS INC | ELVN | 152,178 | $3.6M | 1.34% |
| 23 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 71,442 | $1.9M | 0.73% |
| 24 | RAPPORT THERAPEUTICS INC | RAPP | 70,000 | $1.6M | 0.62% |
| 25 | MORPHIC HLDG INC | 61775R105 | 47,660 | $1.6M | 0.61% |
| 26 | CONTINEUM THERAPEUTICS INC | CTNM | 72,831 | $1.3M | 0.48% |